Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Prostate Stem Cell Antigen Single Nucleotide Polymorphisms Influence Risk of Estrogen Receptor Negative Breast Cancer in Korean Females

  • Kim, Sook-Young (Cancer Genomics Branch, National Cancer Center) ;
  • Yoo, Jae-Young (Cancer Genomics Branch, National Cancer Center) ;
  • Shin, Ae-Sun (Molecular Epidemiology Branch, National Cancer Center) ;
  • Kim, Yeon-Ju (Cancer Early Detection Branch, National Cancer Center) ;
  • Lee, Eun-Sook (Convergence Technology Division, National Cancer Center) ;
  • Lee, Yeon-Su (Cancer Genomics Branch, National Cancer Center)
  • Published : 2012.01.31
Download PDF
⟨ Previous Next ⟩

Abstract

Introduction: Breast cancer is the second leading cancer in Korean women. To assess potential genetic associations between the prostate stem cell antigen (PSCA) gene in the chromosome 8q24 locus and breast cancer risk in Korean women, 13 SNPs were selected and associations with breast cancer risk were analyzed with reference to hormone receptor (HR) and menopausal status. Methods:We analyzed DNA extracted from buffy coat from 456 patients and 461 control samples, using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) based upon region-specific PCR followed by allelespecific single base primer extension reactions. Risks associated with PSCA genotypes and haplotypes were estimated with chi-square test (${\chi}^2$-test), and polytomous logistic regression models using odds ratios (OR) and 95% confidence intervals (CIs), by HR and menopausal status. Results: In case-control analysis, odds ratios (OR) of rs2294009, rs2294008, rs2978981, rs2920298, rs2976395, and rs2976396 were statistically significant only among women with estrogen receptor (ER) negative cancers, and those of rs2294008, rs2978981, rs2294010, rs2920298, rs2976394, rs10216533, and rs2976396 were statistically significant only in pre-menopausal women, and not in postmenopausal women. Risk with the TTGGCAA haplotype was significantly elevated in ER (-) status (OR= 1.48, 95% CI= 1.03~2.12, p<0.05). Especially risk of allele T of rs2294008 is significantly low in pre-menopausal breast cancer patients and AA genotype of rs2976395 in ER (-) status represents the increase of OR value. Conclusion: This report indicated for the first time that associations exist between PSCA SNPs and breast cancer susceptibility in Korean women, particularly those who are pre-menopausal with an estrogen receptor negative tumor status.

Keywords

References

  1. AleAhmad S, Casey G, Sweeney P, et al (2009). Prostate stem cell antigen DNA vaccination breaks tolerance to selfantigen and inhibits prostate cancer growth. Mol Ther, 17, 1101-8. https://doi.org/10.1038/mt.2009.66
  2. Ahn SH (2004). Clinical characteristics of breast cancer patients in Korea in 2000. Arch Surg, 139, 27-30, discussion 1. https://doi.org/10.1001/archsurg.139.1.27
  3. Benson JR, Jatoi I, Keisch M, et al. (2009). Early breast cancer. Lancet, 373, 1463-79. https://doi.org/10.1016/S0140-6736(09)60316-0
  4. Berndt SI, Potter JD, Hazra A, et al. (2008). Pooled analysis of genetic variation at chromosome 8q24 and colorectal neoplasia risk. Hum Mol Genet, 17, 2665-72. https://doi.org/10.1093/hmg/ddn166
  5. Buck MB, Fritz P, Dippon J, et al. (2004). Prognostic significance of transforming growth factor beta receptor II in estrogen receptor-negative breast cancer patients. Clin Cancer Res, 10, 491-8. https://doi.org/10.1158/1078-0432.CCR-0320-03
  6. Chen JQ, Brown TR, Russo J (2009). Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors. Biochim Biophys Acta, 1793, 1128-43. https://doi.org/10.1016/j.bbamcr.2009.03.009
  7. Chu LW, Meyer TE, Li Q, et al. (2010). Association between genetic variants in the 8q24 cancer risk regions and circulating levels of androgens and sex hormone-binding globulin. Cancer Epidemiol Biomarkers Prev, 19, 1848- 54. https://doi.org/10.1158/1055-9965.EPI-10-0101
  8. Cianfrocca M, Gradishar W (2009). New molecular classifications of breast cancer. CA Cancer J Clin, 59, 303-13. https://doi.org/10.3322/caac.20029
  9. Coffey DS (2001). Similarities of prostate and breast cancer: Evolution, diet, and estrogens. Urology, 57, 31-8. https://doi.org/10.1016/S0090-4295(00)00938-9
  10. Czajka-Oraniec I, Simpson ER (2010). Aromatase research and its clinical significance. Endokrynol Pol, 61, 126-34.
  11. Ferlay J, Shin HR, Bray F, et al. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
  12. Fletcher O, Johnson N, Gibson L, et al. (2008). Association of genetic variants at 8q24 with breast cancer risk. Cancer Epidemiol Biomarkers Prev, 17, 702-5. https://doi.org/10.1158/1055-9965.EPI-07-2564
  13. Frasor J, Danes JM, Komm B, et al. (2003). Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology, 144, 4562-74. https://doi.org/10.1210/en.2003-0567
  14. Garcia-Closas M, Chanock S (2008). Genetic susceptibility loci for breast cancer by estrogen receptor status. Clin Cancer Res, 14, 8000-9. https://doi.org/10.1158/1078-0432.CCR-08-0975
  15. Gluz O, Liedtke C, Gottschalk N, et al. (2009). Triple-negative breast cancer--current status and future directions. Ann Oncol, 20, 1913-27. https://doi.org/10.1093/annonc/mdp492
  16. Habel LA, Capra AM, Oestreicher N, et al. (2007). Mammographic density in a multiethnic cohort. Menopause, 14, 891-9. https://doi.org/10.1097/gme.0b013e318032569c
  17. Han JS, Cao D, Molberg KH, et al. (2011). Hormone receptor status rather than HER2 status is significantly associated with increased Ki-67 and p53 expression in triplenegative breast carcinomas, and high expression of Ki-67 but not p53 is significantly associated with axillary nodal metastasis in triple-negative and high-grade non-triplenegative breast carcinomas. Am J Clin Pathol, 135, 230-7. https://doi.org/10.1309/AJCP9DV3EVZUATFV
  18. Imyanitov EN (2009). Gene polymorphisms, apoptotic capacity and cancer risk. Hum Genet, 125, 239-46. https://doi.org/10.1007/s00439-009-0636-7
  19. Jung KW, Park S, Kong HJ, et al. (2011). Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat, 43, 1-11. https://doi.org/10.4143/crt.2011.43.1.1
  20. Kim BK, Lee JW, Park PJ, et al. (2009). The multiplex bead array approach to identifying serum biomarkers associated with breast cancer. Breast Cancer Res, 11, R22. https://doi.org/10.1186/bcr2247
  21. Li J, Humphreys K, Heikkinen T, et al. (2010). A combined analysis of genome-wide association studies in breast cancer. Breast Cancer Res Treat.
  22. Lopez-Otin C, Diamandis EP (1998). Breast and prostate cancer: an analysis of common epidemiological, genetic, and biochemical features. Endocr Rev, 19, 365-96. https://doi.org/10.1210/er.19.4.365
  23. Matera L (2010). The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer. Cancer Treat Rev, 36, 131-41. https://doi.org/10.1016/j.ctrv.2009.11.002
  24. Matsuo K, Tajima K, Suzuki T, et al. (2009). Association of prostate stem cell antigen gene polymorphisms with the risk of stomach cancer in Japanese. Int J Cancer, 125, 1961-4. https://doi.org/10.1002/ijc.24519
  25. Offit K, Robson ME (2010). New pharmacogenomic paradigm in breast cancer treatment. J Clin Oncol, 28, 4665-6. https://doi.org/10.1200/JCO.2010.31.2926
  26. Onay VU, Briollais L, Knight JA, et al. (2006). SNP-SNP interactions in breast cancer susceptibility. BMC Cancer, 6, 114. https://doi.org/10.1186/1471-2407-6-114
  27. Orlando L, Schiavone P, Fedele P, et al. (2010). Molecularly targeted endocrine therapies for breast cancer. Cancer Treat Rev, 36 Suppl 3, S67-71. https://doi.org/10.1016/S0305-7372(10)70023-2
  28. Ozet A, Yavuz AA, Komurcu S, et al. (2000). Bilateral male breast cancer and prostate cancer: a case report. Jpn J Clin Oncol, 30, 188-90. https://doi.org/10.1093/jjco/hyd050
  29. Raff AB, Gray A, Kast WM (2009). Prostate stem cell antigen: a prospective therapeutic and diagnostic target. Cancer Lett, 277, 126-32. https://doi.org/10.1016/j.canlet.2008.08.034
  30. Reiter RE, Gu Z, Watabe T, et al. (1998). Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci U S A, 95, 1735-40. https://doi.org/10.1073/pnas.95.4.1735
  31. Rochefort H, Glondu M, Sahla ME, et al. (2003). How to target estrogen receptor-negative breast cancer? Endocr Relat Cancer, 10, 261-6. https://doi.org/10.1677/erc.0.0100261
  32. Rugo HS (2008). The breast cancer continuum in hormonereceptor- positive breast cancer in postmenopausal women: evolving management options focusing on aromatase inhibitors. Ann Oncol, 19, 16-27. https://doi.org/10.1093/annonc/mdn300
  33. Sakamoto H, Yoshimura K, Saeki N, et al (2008). Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet, 40, 730-40. https://doi.org/10.1038/ng.152
  34. Smith LF (2007). Palpable cancer of the breast and negative mammography: the ongoing dilemma. J Surg Oncol, 96, 451-2. https://doi.org/10.1002/jso.20800
  35. Thomas G, Jacobs KB, Kraft P, et al. (2009). A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet, 41, 579-84. https://doi.org/10.1038/ng.353
  36. Uray IP, Brown PH (2011). Chemoprevention of hormone receptor-negative breast cancer: new approaches needed. Recent Results Cancer Res, 188, 147-62.
  37. Wiechec E, Hansen LL (2009). The effect of genetic variability on drug response in conventional breast cancer treatment. Eur J Pharmacol, 625, 122-30. https://doi.org/10.1016/j.ejphar.2009.08.045
  38. Williams C, Brunskill S, Altman D, et al. (2006). Costeffectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy. Health Technol Assess, 10, iii-iv, ix-xi, 1-204.
  39. Wu X, Ye Y, Kiemeney LA, et al. (2009). Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet, 41, 991-5. https://doi.org/10.1038/ng.421
  40. Yang X, Lippman ME (1999). BRCA1 and BRCA2 in breast cancer. Breast Cancer Res Treat, 54, 1-10. https://doi.org/10.1023/A:1006189906896
  41. Yeager M, Xiao N, Hayes RB, et al. (2008). Comprehensive resequence analysis of a 136 kb region of human chromosome 8q24 associated with prostate and colon cancers. Hum Genet, 124, 161-70. https://doi.org/10.1007/s00439-008-0535-3

Cited by

  1. Characterization and function of human Ly-6/uPAR molecules vol.45, pp.11, 2012, https://doi.org/10.5483/BMBRep.2012.45.11.210
  2. Histone Deacetylases and their Inhibitors as Potential Therapeutic Drugs for cholangiocarcinoma - Cell Line findings vol.14, pp.4, 2013, https://doi.org/10.7314/APJCP.2013.14.4.2503
  3. Prostate stem cell antigen and cancer risk, mechanisms and therapeutic implications vol.14, pp.1, 2014, https://doi.org/10.1586/14737140.2014.845372
  4. Effect of Trichostatin A on CNE2 Nasopharyngeal Carcinoma Cells - Genome-wide DNA Methylation Alteration vol.15, pp.11, 2014, https://doi.org/10.7314/APJCP.2014.15.11.4663
  5. C13orf18 and C1orf166 (MULAN) DNA Genes Methylation are Not Associated with Cervical Cancer and Precancerous Lesions of Human Papillomavirus Genotypes in Iranian Women vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6745
  6. PSCA rs2294008 Polymorphism with Increased Risk of Cancer vol.10, pp.8, 2015, https://doi.org/10.1371/journal.pone.0136269
  7. PSCA rs2294008 polymorphism contributes to the decreased risk for cervical cancer in a Chinese population vol.6, pp.1, 2016, https://doi.org/10.1038/srep23465
  8. Gene alterations and epigenetic changes in intrahepatic cholangiocarcinoma vol.17, pp.1, 2017, https://doi.org/10.1080/14737140.2017.1266261
  9. The Influence of PSCA Gene Variation on Its Expression and Gastric Adenocarcinoma Susceptibility in the Northwest Chinese Population vol.16, pp.12, 2015, https://doi.org/10.3390/ijms160511648
  10. Impact of DCC (rs714) and PSCA (rs2294008 and rs2976392) Gene Polymorphism in Modulating Cancer Risk in Asian Population vol.7, pp.2, 2016, https://doi.org/10.3390/genes7020009